PortfoliosLab logo
MNMD vs. CMPS
Performance
Risk-Adjusted Performance
Dividends
Drawdowns
Volatility
Financials

Correlation

The correlation between MNMD and CMPS is 0.34, which is considered to be low. This implies their price changes are not closely related. A low correlation is generally favorable for portfolio diversification, as it helps to reduce overall risk by spreading it across multiple assets with different performance patterns.


-0.50.00.51.0
Correlation: 0.3

Performance

MNMD vs. CMPS - Performance Comparison

The chart below illustrates the hypothetical performance of a $10,000 investment in Mind Medicine (MindMed) Inc. (MNMD) and COMPASS Pathways plc (CMPS). The values are adjusted to include any dividend payments, if applicable.

-100.00%-50.00%0.00%50.00%NovemberDecember2025FebruaryMarchApril
8.16%
-86.62%
MNMD
CMPS

Key characteristics

Sharpe Ratio

MNMD:

-0.32

CMPS:

-0.73

Sortino Ratio

MNMD:

0.04

CMPS:

-0.90

Omega Ratio

MNMD:

1.00

CMPS:

0.89

Calmar Ratio

MNMD:

-0.27

CMPS:

-0.55

Martin Ratio

MNMD:

-0.81

CMPS:

-1.29

Ulcer Index

MNMD:

30.73%

CMPS:

40.48%

Daily Std Dev

MNMD:

78.89%

CMPS:

71.94%

Max Drawdown

MNMD:

-96.96%

CMPS:

-95.51%

Current Drawdown

MNMD:

-90.96%

CMPS:

-93.45%

Fundamentals

Market Cap

MNMD:

$485.80M

CMPS:

$369.77M

EPS

MNMD:

-$1.54

CMPS:

-$2.34

PS Ratio

MNMD:

0.00

CMPS:

0.00

PB Ratio

MNMD:

1.95

CMPS:

2.29

Total Revenue (TTM)

MNMD:

$0.00

CMPS:

$0.00

EBITDA (TTM)

MNMD:

-$52.43M

CMPS:

-$122.32M

Returns By Period

In the year-to-date period, MNMD achieves a -8.62% return, which is significantly lower than CMPS's 2.65% return.


MNMD

YTD

-8.62%

1M

2.75%

6M

-4.36%

1Y

-25.35%

5Y*

-0.95%

10Y*

N/A

CMPS

YTD

2.65%

1M

31.97%

6M

-38.99%

1Y

-51.13%

5Y*

N/A

10Y*

N/A

*Annualized

Compare stocks, funds, or ETFs

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.


Risk-Adjusted Performance

MNMD vs. CMPS — Risk-Adjusted Performance Rank

Compare risk-adjusted metric ranks to identify better-performing investments over the past 12 months.

MNMD
The Risk-Adjusted Performance Rank of MNMD is 3636
Overall Rank
The Sharpe Ratio Rank of MNMD is 3434
Sharpe Ratio Rank
The Sortino Ratio Rank of MNMD is 3939
Sortino Ratio Rank
The Omega Ratio Rank of MNMD is 3838
Omega Ratio Rank
The Calmar Ratio Rank of MNMD is 3535
Calmar Ratio Rank
The Martin Ratio Rank of MNMD is 3434
Martin Ratio Rank

CMPS
The Risk-Adjusted Performance Rank of CMPS is 1616
Overall Rank
The Sharpe Ratio Rank of CMPS is 1313
Sharpe Ratio Rank
The Sortino Ratio Rank of CMPS is 1515
Sortino Ratio Rank
The Omega Ratio Rank of CMPS is 1717
Omega Ratio Rank
The Calmar Ratio Rank of CMPS is 1717
Calmar Ratio Rank
The Martin Ratio Rank of CMPS is 1616
Martin Ratio Rank
The risk-adjusted ranks indicate the investment's position relative to the market. A rank closer to 100 signifies top-performing investments, while a rank closer to 0 might suggest underperformance, based on the selected ratio. The values are calculated based on the past 12 months of returns.

MNMD vs. CMPS - Risk-Adjusted Performance Comparison

This table presents a comparison of risk-adjusted performance metrics for Mind Medicine (MindMed) Inc. (MNMD) and COMPASS Pathways plc (CMPS). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.


The chart of Sharpe ratio for MNMD, currently valued at -0.32, compared to the broader market-2.00-1.000.001.002.003.00
MNMD: -0.32
CMPS: -0.73
The chart of Sortino ratio for MNMD, currently valued at 0.04, compared to the broader market-6.00-4.00-2.000.002.004.00
MNMD: 0.04
CMPS: -0.90
The chart of Omega ratio for MNMD, currently valued at 1.00, compared to the broader market0.501.001.502.00
MNMD: 1.00
CMPS: 0.89
The chart of Calmar ratio for MNMD, currently valued at -0.27, compared to the broader market0.001.002.003.004.005.00
MNMD: -0.27
CMPS: -0.55
The chart of Martin ratio for MNMD, currently valued at -0.81, compared to the broader market-5.000.005.0010.0015.0020.00
MNMD: -0.81
CMPS: -1.29

The current MNMD Sharpe Ratio is -0.32, which is higher than the CMPS Sharpe Ratio of -0.73. The chart below compares the historical Sharpe Ratios of MNMD and CMPS, offering insights into how both investments have performed under varying market conditions. These values are calculated using daily returns over the previous 12 months.


Rolling 12-month Sharpe Ratio-1.000.001.002.003.00NovemberDecember2025FebruaryMarchApril
-0.32
-0.73
MNMD
CMPS

Dividends

MNMD vs. CMPS - Dividend Comparison

Neither MNMD nor CMPS has paid dividends to shareholders.


Tickers have no history of dividend payments

Drawdowns

MNMD vs. CMPS - Drawdown Comparison

The maximum MNMD drawdown since its inception was -96.96%, roughly equal to the maximum CMPS drawdown of -95.51%. Use the drawdown chart below to compare losses from any high point for MNMD and CMPS. For additional features, visit the drawdowns tool.


-96.00%-94.00%-92.00%-90.00%-88.00%-86.00%NovemberDecember2025FebruaryMarchApril
-90.96%
-93.45%
MNMD
CMPS

Volatility

MNMD vs. CMPS - Volatility Comparison

Mind Medicine (MindMed) Inc. (MNMD) has a higher volatility of 28.50% compared to COMPASS Pathways plc (CMPS) at 25.24%. This indicates that MNMD's price experiences larger fluctuations and is considered to be riskier than CMPS based on this measure. The chart below showcases a comparison of their rolling one-month volatility.


15.00%20.00%25.00%30.00%35.00%NovemberDecember2025FebruaryMarchApril
28.50%
25.24%
MNMD
CMPS

Financials

MNMD vs. CMPS - Financials Comparison

This section allows you to compare key financial metrics between Mind Medicine (MindMed) Inc. and COMPASS Pathways plc. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.


Quarterly
Annual

Total Revenue: Total amount of money received from sales and other business activities


Values in USD except per share items